Positive Phase 1/2 Clinical Trial Results of Genethon's Gene

Positive Phase 1/2 Clinical Trial Results of Genethon's Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Published in The New England Journal of Medicine

Positive Phase 1/2 Clinical Trial Results of Genethon's Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Published in The New England Journal of Medicine

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Italy , Labrune , Picardie , France , Clamart , France General , Amsterdam , Noord Holland , Netherlands , Piter Bosma , Frederic Revah , Marion Delbouis , Charles Craig , Opus Biotech Communications , Ulrich Beuers Academic Medical Center , New England Journal , Crigler Najjar Syndrome , Antiga Azienda Ospedaliera Papa Giovanni , Aktien Sie ,